Back
Regulus Therapeutics Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Buy
55
RGLS
Regulus Therapeutics
Last Price:
$7.89
Seasonality Move:
-22.72%
7 Day Trial
ALL ACCESS PASS
$
7
How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
The current trend is moderately bearish and RGLS is experiencing slight selling pressure.
Regulus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.2 | Buy |
| 20-day SMA: | 8.06 | Buy |
| 50-day SMA: | 6.26 | Buy |
| 200-day SMA: | 2.67 | Buy |
| 8-day EMA: | 8.17 | Buy |
| 20-day EMA: | 7.92 | Buy |
| 50-day EMA: | 6.51 | Buy |
| 200-day EMA: | 3.51 | Buy |
Regulus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 77.92 | Buy |
| Chaikin Money Flow: | -455292 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Regulus Therapeutics Technical Analysis
| Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Regulus Therapeutics Stock
Is Regulus Therapeutics Stock a Buy?
-
Regulus Therapeutics share price is 8.21 while RGLS 8-day simple moving average is 8.20, which is a Buy signal.
-
The stock price of RGLS is 8.21 while Regulus Therapeutics 20-day SMA is 8.06, which makes it a Buy.
-
Regulus Therapeutics 50-day simple moving average is 6.26 while RGLS share price is 8.21, making it a Buy technically.
-
RGLS stock price is 8.21 and Regulus Therapeutics 200-day simple moving average is 2.67, creating a Buy signal.
RGLS Technical Analysis vs Fundamental Analysis
Buy
55
Regulus Therapeutics (RGLS)
is a Buy
Is Regulus Therapeutics a Buy or a Sell?
-
Regulus Therapeutics stock is rated a BuyThe current Regulus Therapeutics [RGLS] share price is $8.21. The Score for RGLS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Regulus Therapeutics Stock Info
Market Cap:
568.4M
Price in USD:
8.21
Share Volume:
1.4M
Regulus Therapeutics 52-Week Range
52-Week High:
8.35
52-Week Low:
0.83
Buy
55
Regulus Therapeutics (RGLS)
is a Buy
Regulus Therapeutics Share Price Forecast
-
What is the Regulus Therapeutics stock price today?The Regulus Therapeutics stock price is 8.21 USD today.
-
Will RGLS stock go up or go down?Regulus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Regulus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regulus Therapeutics is not overvalued.
Is Regulus Therapeutics Stock a Buy?
-
Regulus Therapeutics share price is 8.21 while RGLS 8-day exponential moving average is 8.17, which is a Buy signal.
-
The stock price of RGLS is 8.21 while Regulus Therapeutics 20-day EMA is 7.92, which makes it a Buy.
-
Regulus Therapeutics 50-day exponential moving average is 6.51 while RGLS share price is 8.21, making it a Buy technically.
-
RGLS stock price is 8.21 and Regulus Therapeutics 200-day simple moving average is 3.51, creating a Buy signal.
Fundamental Analysis of Regulus Therapeutics
Is Regulus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.09 per share, and a decrease next year of $0.22 per share.
Technical Analysis of Regulus Therapeutics
Should I short Regulus Therapeutics stock?
-
RGLS Moving Average Covergence Divergence (MACD) indicator is 0.45, suggesting Regulus Therapeutics is a Buy
-
Regulus Therapeutics Relative Strength Index (RSI) is 77.92, which suggest Regulus Therapeutics is overbought
-
The Bollinger Bands (25) for Regulus Therapeutics is ( - ), which suggest Regulus Therapeutics is a Buy
-
The Bollinger Bands (100) for Regulus Therapeutics is ( - ), which suggest Regulus Therapeutics is a Buy
* Regulus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.